242 related articles for article (PubMed ID: 12649932)
21. Molecular characterization of the env gene of two CCR5/CXCR4-independent human immunodeficiency 2 primary isolates.
Santos-Costa Q; Parreira R; Moniz-Pereira J; Azevedo-Pereira JM
J Med Virol; 2009 Nov; 81(11):1869-81. PubMed ID: 19774680
[TBL] [Abstract][Full Text] [Related]
22. The HIV coreceptor switch: a population dynamical perspective.
Regoes RR; Bonhoeffer S
Trends Microbiol; 2005 Jun; 13(6):269-77. PubMed ID: 15936659
[TBL] [Abstract][Full Text] [Related]
23. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.
Kedzierska K; Crowe SM; Turville S; Cunningham AL
Rev Med Virol; 2003; 13(1):39-56. PubMed ID: 12516061
[TBL] [Abstract][Full Text] [Related]
24. CCR5 antagonists: a new tool in fighting HIV.
Jülg B; Goebel FD
J HIV Ther; 2005 Dec; 10(4):68-71. PubMed ID: 16519245
[TBL] [Abstract][Full Text] [Related]
25. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
26. [Chemokines and their receptors: 2 new actors in the physiopathology of HIV infection].
Davaro RE; Bottaro E
Medicina (B Aires); 1998; 58(1):78-84. PubMed ID: 9674213
[TBL] [Abstract][Full Text] [Related]
27. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4.
Wang J; Alvarez R; Roderiquez G; Guan E; Norcross MA
J Cell Biochem; 2004 Nov; 93(4):753-60. PubMed ID: 15660419
[TBL] [Abstract][Full Text] [Related]
28. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.
Doms RW; Peiper SC
Virology; 1997 Sep; 235(2):179-90. PubMed ID: 9281497
[No Abstract] [Full Text] [Related]
29. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
30. Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by beta-chemokines (RANTES) in primary human macrophages.
Stantchev TS; Broder CC
J Infect Dis; 2000 Jul; 182(1):68-78. PubMed ID: 10882583
[TBL] [Abstract][Full Text] [Related]
31. Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines.
Bai X; Chen JD; Yang AG; Torti F; Chen SY
Gene Ther; 1998 Jul; 5(7):984-94. PubMed ID: 9813670
[TBL] [Abstract][Full Text] [Related]
32. R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.
Saïdi H; Magri G; Nasreddine N; Réquena M; Bélec L
Virology; 2007 Feb; 358(1):55-68. PubMed ID: 16934308
[TBL] [Abstract][Full Text] [Related]
33. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.
Amara A; Gall SL; Schwartz O; Salamero J; Montes M; Loetscher P; Baggiolini M; Virelizier JL; Arenzana-Seisdedos F
J Exp Med; 1997 Jul; 186(1):139-46. PubMed ID: 9207008
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
35. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
36. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
38. Expression of human immunodeficiency virus coreceptors CXC chemokine receptor 4 and CC chemokine receptor 5 on monocytes is down-regulated during human endotoxemia.
Juffermans NP; Weijer S; Verbon A; Speelman P; van der Poll T
J Infect Dis; 2002 Apr; 185(7):986-9. PubMed ID: 11920324
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
[TBL] [Abstract][Full Text] [Related]
40. Clarifying the role of G protein signaling in HIV infection: new approaches to an old question.
Juno JA; Fowke KR
AIDS Rev; 2010; 12(3):164-76. PubMed ID: 20842205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
